AGP Picks
View all

Amesite Signs New 2,000-Patient NurseMagic® Enterprise Customer, Extending Growth Among Large Healthcare Organizations

News originally published by

GlobeNewswire

Amesite announces its latest major enterprise win, increasing its revenue and deploying AI automations for another large healthcare organization in just days on its secure, AI-native infrastructure

DETROIT, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), an adaptive AI technology company and developer of the AI-native NurseMagic® documentation platform and LynkMagic™ enterprise solutions, today announced a new NurseMagic® enterprise agreement with a healthcare organization serving approximately 2,000 patients.

The contract ramps Amesite’s revenue, user base and patient census, and demonstrates another large company win for the Company’s portfolio. This announcement follows other substantial wins including a sales win under the minimum pricing model, a 2,700-census enterprise customer win in May 2026, a trading partner agreement enabling secure connectivity with an established homecare technology platform in March 2026, and the launch of its AI-native NurseMagic® EMR in December 2025. These milestones demonstrate continued execution of the Company's strategy to expand NurseMagic® adoption among larger healthcare organizations.

Amesite combines AI-native engineering with enterprise-scale execution, deploying sophisticated, production-ready AI systems in days rather than months. This capability enables Amesite to deliver enterprise-scale solutions with exceptional speed and efficiency, supporting attractive, high-margin subscription economics for mid-sized organizations while meeting the complex demands of large healthcare enterprises.

Dr. Ann Marie Sastry, Founder and CEO of Amesite, said, “We demonstrate production-ready AI systems during enterprise sales discussions and deploy customer-specific capabilities in days, not months. Our AI-native infrastructure enables us to meet complex healthcare requirements without lengthy development cycles or replacement of customers' existing systems. We are now converting these engineering advantages into larger enterprise agreements and recurring revenue opportunities.”

NurseMagic® automates work beyond transcription, transforming patient encounters into structured documentation and completing customer-specific electronic medical record (EMR) assessments, care plans, and forms. Its production capabilities include identifying missing information, generating targeted follow-up questions, and populating existing EMR workflows. NurseMagic® Record adds secure ambient and mobile recording, including offline capture with automatic synchronization when connectivity returns.

Together, these capabilities enable sophisticated enterprise automation within existing healthcare infrastructure. No rip and replace.

Kalie Wortinger, Head of Engineering at Amesite, said, “Our AI-native engineering infrastructure enables us to deliver increasingly sophisticated enterprise solutions at exceptional speed. We now ship more than 13 times as much code each quarter as we did in the first quarter of 2025, with another 37% increase in the third quarter of 2026 over the second quarter, all without adding engineers. By building customer-specific capabilities on our existing secure, HIPAA-aligned infrastructure, we can bring new products into production in days and deliver new features in hours, allowing us to serve increasingly complex healthcare enterprises efficiently and at scale.”

Sai K. Nittala, Head of AI at Amesite, said, “Large healthcare organizations have established technology stacks, but many of the documentation tasks within those systems remain entrenched, tedious, and expensive to perform. Our agility allows us to fill those gaps quickly with AI capabilities tailored to different care settings and operational requirements. We deliver complex customer-specific solutions and sit on top of existing systems. This enables us to build value and ramp sales with large enterprises, without rebuilding our core platform.”

Madison Bush, Director of Corporate Operations at Amesite, said, "Our marketing results are measurable: median customer census at signing has increased 4x from 2025 to 2026, demonstrating our progress in attracting larger organizations and converting market intelligence into enterprise sales.”

Amesite has methodically expanded its customer base with increasingly large healthcare market segments, progressing from hospice and home care to skilled nursing, senior living, and enterprise workflows serving Medicare and Medicaid populations. Each expansion has built on the Company's existing AI infrastructure, positioning Amesite to serve increasingly complex organizations across the U.S. non-acute and post-acute healthcare markets.

This most recent contract win expands Amesite’s customer portfolio into healthcare services for rural Medicare and Medicaid populations. Across the U.S., this segment comprises 64.5 million rural Americans, including 17.8 million Medicaid enrollees and 11.8 million Medicare beneficiaries. Based on projected 2026 spending per enrollee, these populations represent an estimated $232.9 billion in annual Medicaid spending and $224.0 billion in Medicare spending, respectively, totaling approximately $456.9 billion in combined annual healthcare spending. Overall, segments represented by customers in Amesite's portfolio have a combined estimated U.S. market size of approximately $1.5 trillion.

About Amesite Inc.

Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $1.5 trillion non-acute care segments. Its flagship product, NurseMagic®, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic® is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance.

Built on proprietary AI trained on industry-specific data, NurseMagic® meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages.

Forward-Looking Statement

This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company and its business.

Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements.

Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its business are set forth in the Company's filings with the SEC.

Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations

ir@amesite.com


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Liechtenstein Business Focus

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.